Skip to content

LENSAR, Inc. LNSR Proceeds From Acquisition Related Deposit

Proceeds From Acquisition Related Deposit at other companies

KLR
Kalaris Therapeutics, Inc. Common StockKLRS
$102.11M
Guardian Pharmacy Services logo
Guardian Pharmacy ServicesGRDN
$627.25K
SEI Investments logo
SEI InvestmentsSEIC
$64.84M
Gaming and Leisure Properties logo
Gaming and Leisure PropertiesGLPI
$0-100%
Vail Resorts logo
Vail ResortsMTN
$0
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$0-100%

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-47.4%
Enterprise value$65.21M-49.0%
P/E2.4×
P/S1.2×-1.1×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Reported directly by LENSAR, Inc. in its filing.

Tagged under the XBRL concept lnsr:ProceedsFromAcquisitionRelatedDeposit.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s proceeds from acquisition related deposit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s proceeds from acquisition related deposit?
LENSAR, Inc. (LNSR) reported proceeds from acquisition related deposit of $10M in Q1 2025.
What does proceeds from acquisition related deposit mean?
This represents cash inflows received from the return or settlement of deposits previously held in connection with potential or completed business acquisitions. It highlights liquidity events related to the company's inorganic growth strategy and capital deployment activities.